Combinent BioMedical Systems, a drug-delivery company, pulls in $3M
Combinent BioMedical Systems, a Cambridge, Mass., developer of a vaginal drug-delivery technology, raised $3 million in a first round of financing.
The round was led by Cytyc Development, a subsidiary of women’s health company Cytyc. Other investors include VIMAC Ventures and Commons Capital. Combinent is developing new combinations and formulations of drugs that can be administered via a permeable polymer ring fitted into the vagina.
A Cytyc release describes the financing here.
Next Story: Buzzlogic shows which bloggers have power, and where
Previous Story: DNA sequencer Helicos BioSciences aims to raise $81M in IPO
About the Author, David P. Hamilton
David Hamilton has been writing for VentureBeat LifeScience since April 2007. He formerly spent 14 years as a reporter for the Wall Street Journal in its San Francisco and Tokyo bureaus. Prior to that, he spent several years as a reporter at Science Magazine and as a reporter/researcher for the New Republic, both in Washington.